# Biotech Daily Digest — 2025-10-29

**43 items from 3 sources**

## Summary by Source

- Endpoints News: 10 items
- Fierce Biotech: 7 items
- arXiv q-bio: 26 items


## Endpoints News

- **[Recursion gets $30M from Roche; Chinese siRNA biotech to go public in Hong Kong](https://endpoints.news/recursion-gets-30m-from-roche-chinese-sirna-biotech-to-go-public-in-hong-kong/)**  
  _Wed, 29 Oct 2025 14:32:31 +0000_  
  

- **[Regeneron teams up with Gary Nabel's ModeX on multispecifics](https://endpoints.news/regeneron-teams-up-with-gary-nabels-modex-on-multispecifics/)**  
  _Wed, 29 Oct 2025 14:22:25 +0000_  
  For decades, Regeneron has been known for its antibody expertise.

 It's now enlisting the help of a biotech run by former NIH leaders to beef up its R&D in the multispecific antibody arena, as bispecifics ...

- **[Weight loss drugs could be cost-effective even at higher prices, ICER says](https://endpoints.news/weight-loss-drugs-could-be-cost-effective-even-at-higher-prices-icer-says/)**  
  _Wed, 29 Oct 2025 12:21:07 +0000_  
  The mounting evidence that Novo Nordisk's and Eli Lilly's blockbuster weight loss drugs provide significant benefits to patients supports even higher prices for the drugs, a major drug pricing watchdog said on Tuesday, in one ...

- **[BridgeBio gets another Phase 3 rare disease win, this time in thyroid disorder](https://endpoints.news/bridgebio-gets-another-phase-3-rare-disease-win-this-time-in-thyroid-disorder/)**  
  _Wed, 29 Oct 2025 11:00:39 +0000_  
  BridgeBio declared another Phase 3 rare disease win Wednesday morning on the heels of a late-stage success earlier this week.

 The biotech’s oral drug encaleret hit the primary endpoint for a genetic thyroid disorder called ...

- **[Lilly keeps up legal fight against GLP-1 compounders](https://endpoints.news/lilly-keeps-up-legal-fight-against-glp-1-compounders/)**  
  _Tue, 28 Oct 2025 19:40:58 +0000_  
  Despite recent setbacks in court, Eli Lilly is doubling down on its fight against compounded weight loss drugs.

 The pharma giant told Endpoints News on Tuesday that it plans to refile its complaint against the ...

- **[FDA clears at-home use for Delix's next neuroplastogen study](https://endpoints.news/fda-clears-at-home-use-for-delixs-next-neuroplastogen-study/)**  
  _Tue, 28 Oct 2025 19:22:46 +0000_  
  Delix Therapeutics has early-stage clinical data showing that its non-hallucinogenic neuroplastogen could be a future depression treatment option. It also said the FDA cleared at-home use of its candidate in a future Phase 2 study ...

- **[Everlywell's at-home testing business evolution](https://endpoints.news/everlywells-at-home-testing-business-evolution/)**  
  _Tue, 28 Oct 2025 18:53:09 +0000_  
  It had been years since I last saw Julia Cheek in person.

 Cheek, the CEO of at-home testing company Everlywell, reminded me when I last saw her in 2019 the company was making about  ...

- **[Eli Lilly, Nvidia say they'll build pharma's most powerful supercomputer](https://endpoints.news/eli-lilly-nvidia-say-theyll-build-pharmas-most-powerful-supercomputer/)**  
  _Tue, 28 Oct 2025 18:30:18 +0000_  
  Eli Lilly and Nvidia have agreed to build what they claim will be life sciences' most powerful supercomputer, with plans to train ever-larger AI models to discover and design medicines.

 “It will allow us to ...

- **[More than a third of Lilly's new Zepbound prescriptions are coming from DTC](https://endpoints.news/more-than-a-third-of-lillys-new-zepbound-prescriptions-are-coming-from-dtc/)**  
  _Tue, 28 Oct 2025 16:28:14 +0000_  
  The impact of pharma’s direct-to-patient efforts is gaining clarity.

 When Eli Lilly launched its LillyDirect program in January 2024, it wasn’t immediately clear how big the business would be. And for a ...

- **[BioMarin looks to divest hemophilia gene therapy Roctavian](https://endpoints.news/biomarin-looks-to-divest-hemophilia-gene-therapy-roctavian/)**  
  _Tue, 28 Oct 2025 15:29:37 +0000_  
  BioMarin announced Monday afternoon that it's exploring ways to divest Roctavian from its portfolio, following a rocky two years since the hemophilia A gene therapy was first approved.

 The move isn't surprising since uptake of ...


## Fierce Biotech

- **[<a href="https://www.fiercebiotech.com/medtech/enable-injections-inks-deal-incyte-leverage-targeted-assets" hreflang="en">Enable Injections, Incyte ink drug delivery collab focused on chronic blood, bone marrow conditions</a>](https://www.fiercebiotech.com/medtech/enable-injections-inks-deal-incyte-leverage-targeted-assets)**  
  _Oct 29, 2025 8:36am_  
  Enable Injections, maker of the enFuse wearable drug delivery system, inked a partnership deal with Incyte to join the companies' technologies in a bid to advance patient care.

- **[<a href="https://www.fiercebiotech.com/biotech/kyverna-links-car-t-improved-autoimmune-outcomes-small-trial" hreflang="en">Kyverna links CAR-T to improved autoimmune outcomes in small trial</a>](https://www.fiercebiotech.com/biotech/kyverna-links-car-t-improved-autoimmune-outcomes-small-trial)**  
  _Oct 29, 2025 10:01am_  
  Kyverna Therapeutics has reported deep, sustained improvements in autoimmune disease patients who received a single dose of its CAR T-cell therapy KYV-101.

- **[<a href="https://www.fiercebiotech.com/cro/roches-flatiron-health-expands-blood-cancer-offerings-six-new-datasets" hreflang="en">Roche's Flatiron Health expands blood cancer offerings with 6 new data sets</a>](https://www.fiercebiotech.com/cro/roches-flatiron-health-expands-blood-cancer-offerings-six-new-datasets)**  
  _Oct 28, 2025 2:21pm_  
  Cancer health tech company Flatiron Health has unveiled six new blood cancer data sets that together comprise information from more than half a million patient records, the Roche subsidiary announced Oct. 29.

- **[<a href="https://www.fiercebiotech.com/biotech/bridgebios-banner-week-rolls-ph-3-win-calcium-deficiency-candidate" hreflang="en">BridgeBio hits phase 3 win for calcium deficiency candidate, plots FDA review next year</a>](https://www.fiercebiotech.com/biotech/bridgebios-banner-week-rolls-ph-3-win-calcium-deficiency-candidate)**  
  _Oct 28, 2025 5:49pm_  
  BridgeBio Pharma is having a banner week, with the Bay Area company’s encaleret acing a phase 3 trial just days after another late-stage rare disease win as it eyes an FDA review in 2026.

- **[<a href="https://www.fiercebiotech.com/biotech/gsk-abandons-hopes-cd226-cancer-therapies-dropping-remaining-phase-2-assets" hreflang="en">GSK abandons hopes for CD226 cancer therapies, dropping remaining phase 2 assets</a>](https://www.fiercebiotech.com/biotech/gsk-abandons-hopes-cd226-cancer-therapies-dropping-remaining-phase-2-assets)**  
  _Oct 29, 2025 6:30am_  
  GSK once dreamed of harnessing the CD226 axis to create a new generation of blockbuster cancer drugs. But that dream appeared to die this morning as the pharma closed the last programs related to this modality.

- **[<a href="https://www.fiercebiotech.com/regulatory/shutdown-tracker-cms-issues-billing-guidance-hhs-furloughs-32000-employees" hreflang="en">How the shutdown impacts healthcare: Judge orders indefinite block on federal worker firings</a>](https://www.fiercebiotech.com/regulatory/shutdown-tracker-cms-issues-billing-guidance-hhs-furloughs-32000-employees)**  
  _Oct 1, 2025 11:56am_  
  The federal government entered a shutdown Oct. 1 after Republicans and Democrats refused to compromise on their funding asks.

- **[<a href="https://www.fiercebiotech.com/biotech/eli-lilly-and-nvidia-set-build-pharmas-largest-ever-supercomputer" hreflang="en">Eli Lilly and Nvidia team up to build 'most powerful' supercomputer in pharma</a>](https://www.fiercebiotech.com/biotech/eli-lilly-and-nvidia-set-build-pharmas-largest-ever-supercomputer)**  
  _Oct 28, 2025 3:13pm_  
  Eli Lilly and computing giant Nvidia are teaming up to build a new supercomputer that the pair say will be the most powerful owned and operated by a pharmaceutical company.


## arXiv q-bio

- **[Genotype-Phenotype Integration through Machine Learning and Personalized Gene Regulatory Networks for Cancer Metastasis Prediction](https://arxiv.org/abs/2510.23620)**  
  _Wed, 29 Oct 2025 00:00:00 -0400_  
  arXiv:2510.23620v1 Announce Type: new 
Abstract: Metastasis is the leading cause of cancer-related mortality, yet most predictive models rely on shallow architectures and neglect patient-specific regulatory mechanisms. Here, we integrate classical machine learning and deep learning to predict metastatic potential acro…

- **[PanDelos-plus: A parallel algorithm for computing sequence homology in pangenomic analysis](https://arxiv.org/abs/2510.23679)**  
  _Wed, 29 Oct 2025 00:00:00 -0400_  
  arXiv:2510.23679v1 Announce Type: new 
Abstract: The identification of homologous gene families across multiple genomes is a central task in bacterial pangenomics traditionally requiring computationally demanding all-against-all comparisons. PanDelos addresses this challenge with an alignment-free and parameter-free a…

- **[Gut decisions based on the liver: A radiomics approach to boost colorectal cancer screening](https://arxiv.org/abs/2510.23687)**  
  _Wed, 29 Oct 2025 00:00:00 -0400_  
  arXiv:2510.23687v1 Announce Type: new 
Abstract: Non-invasive colorectal cancer (CRC) screening represents a key opportunity to improve colonoscopy participation rates and reduce CRC mortality. This study explores the potential of the gut-liver axis for predicting colorectal neoplasia through liver-derived radiomic fe…

- **[Methylator: A Modular Framework for DNA Methylation Analysis in Mammals and Plants Using Galaxy](https://arxiv.org/abs/2510.23783)**  
  _Wed, 29 Oct 2025 00:00:00 -0400_  
  arXiv:2510.23783v1 Announce Type: new 
Abstract: DNA cytosine methylation is a critical epigenetic mark regulating gene expression and thus playing an important role in development and differentiation across eukaryotes. Existing tools for high-throughput methylation analysis often lack cross-species flexibility or req…

- **[On the distributions of restriction sites in human and pangolin sarbecoviruses](https://arxiv.org/abs/2510.23833)**  
  _Wed, 29 Oct 2025 00:00:00 -0400_  
  arXiv:2510.23833v1 Announce Type: new 
Abstract: Since early 2020, several theories have suggested that a distribution of restriction endonuclease recognition sites in the SARS-CoV-2 genome indicates a synthetic origin. The most influential of these, a 2022 preprint by Bruttel et al. claimed: "The BsaI/BsmBI restricti…

- **[Machine learning approaches for interpretable antibody property prediction using structural data](https://arxiv.org/abs/2510.23975)**  
  _Wed, 29 Oct 2025 00:00:00 -0400_  
  arXiv:2510.23975v1 Announce Type: new 
Abstract: Understanding the relationship between antibody sequence, structure and function is essential for the design of antibody-based therapeutics and research tools. Recently, machine learning (ML) models mostly based on the application of large language models to sequence in…

- **[Learning to generalize in evolution through annealed population heterogeneity](https://arxiv.org/abs/2510.24602)**  
  _Wed, 29 Oct 2025 00:00:00 -0400_  
  arXiv:2510.24602v1 Announce Type: new 
Abstract: Evolutionary systems must learn to generalize, often extrapolating from a limited set of selective conditions to anticipate future environmental changes. The mechanisms enabling such generalization remain poorly understood, despite their importance to predict ecological…

- **[Local Electromagnetic Fields Enable Fast Redox Sensing by Physically Accelerating Cysteine Oxidation](https://arxiv.org/abs/2510.24649)**  
  _Wed, 29 Oct 2025 00:00:00 -0400_  
  arXiv:2510.24649v1 Announce Type: new 
Abstract: Hydrogen peroxide oxidises cysteine residues to control protein function, yet bulk rate constants predict hours for changes that occur in cells in seconds. Here, this work shows that local electromagnetic fields (EMFs), ubiquitous in proteins, membranes and nanodomains,…

- **[Integrating Genomics into Multimodal EHR Foundation Models](https://arxiv.org/abs/2510.23639)**  
  _Wed, 29 Oct 2025 00:00:00 -0400_  
  arXiv:2510.23639v1 Announce Type: cross 
Abstract: This paper introduces an innovative Electronic Health Record (EHR) foundation model that integrates Polygenic Risk Scores (PRS) as a foundational data modality, moving beyond traditional EHR-only approaches to build more holistic health profiles. Leveraging the extens…

- **[The Geometry of Contraction-Induced Flows](https://arxiv.org/abs/2510.24016)**  
  _Wed, 29 Oct 2025 00:00:00 -0400_  
  arXiv:2510.24016v1 Announce Type: cross 
Abstract: Peristalsis is the driving mechanism behind a broad array of biological and engineered flows. In peristaltic pumping, a wave-like contraction of the tube wall produces local changes in volume which induce flow. Net flow arises due to geometric nonlinearities in the mo…

- **[Improved Accuracy of Robot Localization Using 3-D LiDAR in a Hippocampus-Inspired Model](https://arxiv.org/abs/2510.24029)**  
  _Wed, 29 Oct 2025 00:00:00 -0400_  
  arXiv:2510.24029v1 Announce Type: cross 
Abstract: Boundary Vector Cells (BVCs) are a class of neurons in the brains of vertebrates that encode environmental boundaries at specific distances and allocentric directions, playing a central role in forming place fields in the hippocampus. Most computational BVC models are…

- **[Low-N Protein Activity Optimization with FolDE](https://arxiv.org/abs/2510.24053)**  
  _Wed, 29 Oct 2025 00:00:00 -0400_  
  arXiv:2510.24053v1 Announce Type: cross 
Abstract: Proteins are traditionally optimized through the costly construction and measurement of many mutants. Active Learning-assisted Directed Evolution (ALDE) alleviates that cost by predicting the best improvements and iteratively testing mutants to inform predictions. How…

- **[Motility-Driven Viscoelastic Control of Tissue Morphology in Presomitic Mesoderm](https://arxiv.org/abs/2510.24314)**  
  _Wed, 29 Oct 2025 00:00:00 -0400_  
  arXiv:2510.24314v1 Announce Type: cross 
Abstract: During development, embryonic tissues experience mechanical stresses ranging from cellular to supracellular length scales. In response, cells generate active forces that drive rearrangements, allowing the tissue to relax accumulated stresses. The nature of these respo…

- **[An N-of-1 Artificial Intelligence Ecosystem for Precision Medicine](https://arxiv.org/abs/2510.24359)**  
  _Wed, 29 Oct 2025 00:00:00 -0400_  
  arXiv:2510.24359v1 Announce Type: cross 
Abstract: Artificial intelligence in medicine is built to serve the average patient. By minimizing error across large datasets, most systems deliver strong aggregate accuracy yet falter at the margins: patients with rare variants, multimorbidity, or underrepresented demographic…

- **[Quantifying the Effects of Word Length, Frequency, and Predictability on Dyslexia](https://arxiv.org/abs/2510.24647)**  
  _Wed, 29 Oct 2025 00:00:00 -0400_  
  arXiv:2510.24647v1 Announce Type: cross 
Abstract: We ask where, and under what conditions, dyslexic reading costs arise in a large-scale naturalistic reading dataset. Using eye-tracking aligned to word-level features (word length, frequency, and predictability), we model how each feature influences dyslexic time cost…

- **[Pearl: A Foundation Model for Placing Every Atom in the Right Location](https://arxiv.org/abs/2510.24670)**  
  _Wed, 29 Oct 2025 00:00:00 -0400_  
  arXiv:2510.24670v1 Announce Type: cross 
Abstract: Accurately predicting the three-dimensional structures of protein-ligand complexes remains a fundamental challenge in computational drug discovery that limits the pace and success of therapeutic design. Deep learning methods have recently shown strong potential as str…

- **[Does Object Binding Naturally Emerge in Large Pretrained Vision Transformers?](https://arxiv.org/abs/2510.24709)**  
  _Wed, 29 Oct 2025 00:00:00 -0400_  
  arXiv:2510.24709v1 Announce Type: cross 
Abstract: Object binding, the brain's ability to bind the many features that collectively represent an object into a coherent whole, is central to human cognition. It groups low-level perceptual features into high-level object representations, stores those objects efficiently a…

- **[Cation-DNA outer sphere coordination in DNA polymorphism](https://arxiv.org/abs/2508.07328)**  
  _Wed, 29 Oct 2025 00:00:00 -0400_  
  arXiv:2508.07328v2 Announce Type: replace 
Abstract: There are two approaches to describing DNA-ions interactions. The physical approach is an analysis of electrostatic interactions between ions and charges on the DNA molecule. The coordination chemistry approach is a search for modes of direct binding of ions to iono…

- **[CFM-GP: Unified Conditional Flow Matching to Learn Gene Perturbation Across Cell Types](https://arxiv.org/abs/2508.08312)**  
  _Wed, 29 Oct 2025 00:00:00 -0400_  
  arXiv:2508.08312v2 Announce Type: replace 
Abstract: Understanding gene perturbation effects across diverse cellular contexts is a central challenge in functional genomics, with important implications for therapeutic discovery and precision medicine. Single-cell technologies enable high-resolution measurement of trans…

- **[A two-size Wright--Fisher model: asymptotic analysis via uniform renewal theory](https://arxiv.org/abs/2502.03056)**  
  _Wed, 29 Oct 2025 00:00:00 -0400_  
  arXiv:2502.03056v2 Announce Type: replace-cross 
Abstract: We consider a population with two types of individuals, distinguished by the resources required for reproduction: type-$0$ (small) individuals need a fractional resource unit of size $\vartheta \in (0,1)$, while type-$1$ (large) individuals require $1$ unit. T…

- **[Multimodal Dreaming: A Global Workspace Approach to World Model-Based Reinforcement Learning](https://arxiv.org/abs/2502.21142)**  
  _Wed, 29 Oct 2025 00:00:00 -0400_  
  arXiv:2502.21142v2 Announce Type: replace-cross 
Abstract: Humans leverage rich internal models of the world to reason about the future, imagine counterfactuals, and adapt flexibly to new situations. In Reinforcement Learning (RL), world models aim to capture how the environment evolves in response to the agent's acti…

- **[Multimodal 3D Genome Pre-training](https://arxiv.org/abs/2504.09060)**  
  _Wed, 29 Oct 2025 00:00:00 -0400_  
  arXiv:2504.09060v2 Announce Type: replace-cross 
Abstract: Deep learning techniques have driven significant progress in various analytical tasks within 3D genomics in computational biology. However, a holistic understanding of 3D genomics knowledge remains underexplored. Here, we propose MIX-HIC, the first multimodal…

- **[A geometric analysis of the Bazykin-Berezovskaya predator-prey model with Allee effect in an economic framework](https://arxiv.org/abs/2504.10355)**  
  _Wed, 29 Oct 2025 00:00:00 -0400_  
  arXiv:2504.10355v2 Announce Type: replace-cross 
Abstract: We study a fast-slow version of the Bazykin-Berezovskaya predator-prey model with Allee effect evolving on two timescales, through the lenses of Geometric Singular Perturbation Theory (GSPT). The system we consider is in non-standard form. We completely charac…

- **[JanusDNA: A Powerful Bi-directional Hybrid DNA Foundation Model](https://arxiv.org/abs/2505.17257)**  
  _Wed, 29 Oct 2025 00:00:00 -0400_  
  arXiv:2505.17257v4 Announce Type: replace-cross 
Abstract: Large language models (LLMs) have revolutionized natural language processing and are increasingly applied to other sequential data types, including genetic sequences. However, adapting LLMs to genomics presents significant challenges. Capturing complex genomic…

- **[NOBLE -- Neural Operator with Biologically-informed Latent Embeddings to Capture Experimental Variability in Biological Neuron Models](https://arxiv.org/abs/2506.04536)**  
  _Wed, 29 Oct 2025 00:00:00 -0400_  
  arXiv:2506.04536v3 Announce Type: replace-cross 
Abstract: Characterizing the cellular properties of neurons is fundamental to understanding their function in the brain. In this quest, the generation of bio-realistic models is central towards integrating multimodal cellular data sets and establishing causal relationsh…

- **[Machine Learning-Enhanced Colorimetric Sensing: Achieving over 5700-fold Accuracy Improvement via Full-Spectrum Modeling](https://arxiv.org/abs/2509.03398)**  
  _Wed, 29 Oct 2025 00:00:00 -0400_  
  arXiv:2509.03398v2 Announce Type: replace-cross 
Abstract: Conventional colorimetric sensing methods typically rely on signal intensity at a single wavelength, often selected heuristically based on peak visual modulation. This approach overlooks the structured information embedded in full-spectrum transmission profile…
